These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 25575144)
21. [Medication errors with concentrated potassium intravenous solutions: Data of the literature, context and prevention]. Charpiat B; Magdinier C; Leboucher G; Aubrun F Ann Pharm Fr; 2016 Jan; 74(1):3-11. PubMed ID: 26298848 [TBL] [Abstract][Full Text] [Related]
22. Influence of the purification of sodium dodecyl sulfate on the physical properties of solutions and O/W emulsions. Arias C; Gómez-Escalonilla I; Rueda C; Molina C Drug Dev Ind Pharm; 1998 Jan; 24(1):95-100. PubMed ID: 15605603 [TBL] [Abstract][Full Text] [Related]
23. [Nursing practices about preparation and administration of oral solutions in psychiatry]. Le Meur-Ringard C; Gaudoneix-Taieb M; Beauverie P Therapie; 2007; 62(6):489-98. PubMed ID: 18316015 [TBL] [Abstract][Full Text] [Related]
24. Parenteral Nutrition Errors and Potential Errors Reported Over the Past 10 Years. Guenter P; Ayers P; Boullata JI; Gura KM; Holcombe B; Sacks GS Nutr Clin Pract; 2017 Dec; 32(6):826-830. PubMed ID: 28662372 [TBL] [Abstract][Full Text] [Related]
25. Physical and chemical stability of proflavine contrast agent solutions for early detection of oral cancer. Kawedia JD; Zhang YP; Myers AL; Richards-Kortum RR; Kramer MA; Gillenwater AM; Culotta KS J Oncol Pharm Pract; 2016 Feb; 22(1):21-5. PubMed ID: 25113309 [TBL] [Abstract][Full Text] [Related]
26. Investigation of the Physical, Chemical, and Microbiological Stability of Oral Solutions Compounded with Herbals. Khokhlova KO; Zdoryk OA Int J Pharm Compd; 2018; 22(3):240-246. PubMed ID: 29878891 [TBL] [Abstract][Full Text] [Related]
28. Parenteral nutrition therapy over the next 5-10 years: where are we heading? DeLegge MH JPEN J Parenter Enteral Nutr; 2012 Mar; 36(2 Suppl):56S-61S. PubMed ID: 22301323 [TBL] [Abstract][Full Text] [Related]
29. Kaneuron: an oral solution of phenobarbital with dangerous packaging. Prescrire Int; 2015 Apr; 24(159):95. PubMed ID: 25941699 [TBL] [Abstract][Full Text] [Related]
30. Clinical Perspectives in Compounding: Compounding Gains and Losses Since I Met "Careless arithmetic nullifies careful compounding". Newton DW Int J Pharm Compd; 2015; 19(6):444-6. PubMed ID: 26891557 [No Abstract] [Full Text] [Related]
31. [SOME COMMENTS ON PREPARATION OF INJECTABLE SOLUTIONS]. CHAUSOVSKII SS Aptechn Delo; 1964; 13():64-6. PubMed ID: 14152093 [No Abstract] [Full Text] [Related]
32. Frequency and Severity of Parenteral Nutrition Medication Errors at a Large Children's Hospital After Implementation of Electronic Ordering and Compounding. MacKay M; Anderson C; Boehme S; Cash J; Zobell J Nutr Clin Pract; 2016 Apr; 31(2):195-206. PubMed ID: 26214511 [TBL] [Abstract][Full Text] [Related]
33. Flecainide toxicity in a pediatric patient due to differences in pharmacy compounding. Wang GS; Tham E; Maes J; Buchanan JA Int J Cardiol; 2012 Nov; 161(3):178-9. PubMed ID: 22749450 [No Abstract] [Full Text] [Related]
34. Basics of Compounding with Dilutions and Concentrates. Allen LV Int J Pharm Compd; 2017; 21(1):39-45. PubMed ID: 28346197 [TBL] [Abstract][Full Text] [Related]
35. Medication errors and drug hydrates. Le Guévello P; Burgot G; Cheverry C Am J Health Syst Pharm; 1997 Jun; 54(12):1449-50. PubMed ID: 9194993 [No Abstract] [Full Text] [Related]
36. The effect of information provision on reduction of errors in intravenous drug preparation and administration by nurses in ICU and surgical wards. Abbasinazari M; Zareh-Toranposhti S; Hassani A; Sistanizad M; Azizian H; Panahi Y Acta Med Iran; 2012; 50(11):771-7. PubMed ID: 23292630 [TBL] [Abstract][Full Text] [Related]
37. Parenteral nutrition training for the pharmacy team: focus on pharmacy technicians. Cassano AT JPEN J Parenter Enteral Nutr; 2012 Mar; 36(2 Suppl):48S-50S. PubMed ID: 22275327 [TBL] [Abstract][Full Text] [Related]
39. Basics of compounding: Tips and hints, part 2: compounding with solutions, suspensions, emulsions, and lotions. Allen LV Int J Pharm Compd; 2014; 18(2):137-8. PubMed ID: 24881118 [No Abstract] [Full Text] [Related]
40. [Pharmacological characteristics and clinical results of efinaconazole (Clenafin® Topical Solution 10%), a novel anti-onychomycosis drug]. Tatsumi Y Nihon Yakurigaku Zasshi; 2015 May; 145(5):250-8. PubMed ID: 25958913 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]